Answers are grounded in this paper and cite their sources.
A new acceptor–donor–acceptor type small molecule acceptor, namely IDT-HN, is developed, which consists of a newly developed 2-(3-oxo-2,3,5,6,7,8-hexahydro-1 H -cyclopenta[ b ]naphthalen-1-ylidene)malononitrile as the peripheral electron-withdrawing group.
No takes yet. Share an insight, caveat, or question.
Li et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: